State of Medtech Podcast

The #1 Podcast for the Medtech Industry Hosted by @omarmkhateeb

[State of Medtech Podcast @StateofMedTech]

Most Companies Skip the First Step of Modern Go-To-Market!
Watch the full episode here: 
https://t.co/IYLKDcZGaL

[Omar M. Khateeb @OmarMKhateeb]

Why Most Go-To-Market Strategies Fail in the AI Era and What https://t.co/FC3dAs1hUD’s CEO Says Elite Companies Do Differently
Most companies still chase growth through more campaigns, more sales hires, and more software layered onto broken systems.
I sat down with Matt Curl, Chief Executive Officer at https://t.co/FC3dAs1hUD, for a sharp conversation on why modern go to market strategy now depends on unified execution across sales, marketing, operations, customer intelligence, automation, and AI native workflows.
Matt breaks down how https://t.co/FC3dAs1hUD scaled into one of the leading AI native go to market platforms while explaining why durable market leadership rarely comes from product strength alone. Distribution, positioning, execution speed, and customer understanding increasingly determine which companies dominate categories.
The conversation also explores account based marketing, AI driven personalization, MedTech commercialization, physician adoption behavior, and why elite companies shape market perception before competitors fully recognize the shift happening around them.
One of the strongest insights from the episode focuses on how AI amplifies operational strengths and weaknesses at the same time. Fragmented systems create faster chaos. Strategic alignment creates faster growth.Exceptional companies no longer treat go to market as isolated activity.
They build intelligent commercial systems designed to compound execution, positioning, customer intelligence, and revenue growth at scale.

Episode Breakdown:

00:00 Why the First 10 Sales Don’t Matter
00:40 Intro + Matt Curl, CEO of https://t.co/FC3dAs1hUD
02:01 What Apollo Does and Why It Matters
03:14 What is Go-To-Market (GTM)?
05:18 The Four Pillars of Modern GTM
08:25 Why Only a Few Thousand Companies Do GTM Well
09:50 COVID, AI, and the Evolution of GTM
11:01 Why the Best Product Doesn't Always Win
13:10 Market Engineering vs Sales Problems
16:25 Why Data is the Oxygen of GTM
18:00 Simple Data Signals That Improve Conversion
19:28 Advanced Data Intelligence Explained
21:18 Category, Messaging, Narrative, and GTM
22:06 Product-Market Fit vs Messaging Failures
24:53 AI and the Future of Personalized GTM
28:01 Apollo’s Category and Market Positioning
30:04 ABM Explained the Right Way
31:42 MedTech, Early Adopters, and Market Selection
34:43 Why Messaging Determines Adoption
36:18 Product-Market Fit vs Market-Product Fit
39:21 How to Find Early Adopters
41:48 What MedTech Gets Wrong About GTM
44:42 Why Relationships Aren’t a Scalable Moat
45:54 The Difference Between 10 Sales and 10,000 Sales
46:36 Why AI Can’t Fix Broken Fundamentals
48:59 The Real Metric That Matters
50:46 The One Trait Shared by Great GTM Teams
51:57 Who Should Own Go-To-Market?
53:18 Why Data-Driven Leaders Win
54:22 Building a Unified GTM System
56:10 Why Winning Customers Creates Winning Companies
58:05 Final GTM Advice for Founders and CEOs
59:29 Outro

[State of Medtech Podcast @StateofMedTech]

The Real Challenge in Cardiology Isn’t Treatment It’s Detection!
Watch the full episode here: 
https://t.co/S2nDIKtO1u

[Omar M. Khateeb @OmarMKhateeb]

Cardiology has a massive data problem hiding inside a detection problem.Most patients enter the system only after symptoms escalate into an emergency event, even though cardiac deterioration often develops silently over years.
I had the chance to speak with Chris Darland, President & CEO of @PeerbridgeCor , about a category that could redefine how healthcare approaches prevention, monitoring, and cardiac triage:Cardiac intelligence platforms.
In this episode we explore how wearable ECG systems are evolving beyond traditional arrhythmia detection into high fidelity intelligence platforms capable of identifying myocardial stress, structural abnormalities, and broader cardiovascular risk much earlier.
We also discuss why proprietary clinical data is becoming one of the strongest defensibility layers in AI driven MedTech, how intelligent routing could help health systems direct patients to the right level of care faster, and why scalable preventive infrastructure may become one of the biggest opportunities in cardiovascular medicine.
For anyone following AI, digital health, diagnostics, or the future of preventive care, this conversation offers a very interesting look at where the market is heading next.

Episode Breakdown

00:00 Why Cardiac Care is Still Reactive
00:53 Intro + Chris Darland and Peerbridge Health
02:00 Growing Up Around Heart Disease
04:30 From GE to MedTech Startup CEO
05:20 The Real Problem in Cardiology Today
06:49 Scaling Cardiac Care Beyond Hospitals
08:00 Heart Failure and Readmission Crisis
09:00 Arrhythmia Monitoring Explained
10:00 Beyond Arrhythmias: Structural Heart Detection
12:00 AI + ECG for Earlier Detection
13:58 Why Most MedTech Startups Fail After FDA
14:05 Cardiac Intelligence Platform Explained
16:00 Using ECG Data to Detect Heart Disease Early
18:00 Why Signal Fidelity Matters
19:30 AI Layer for Personalized Cardiac Insights
21:30 Building a Defensible AI MedTech Company
23:00 Why Hardware + Unique Data Matter
24:08 Regulatory Strategy and FDA Pathway
26:11 Why MedTech Has Strong AI Defensibility
27:30 NASA Signal Processing and SpaceTech Crossover
29:15 Strategic Partnerships and Acquisition Potential
31:00 Detecting Patients Before Critical Events
33:35 AI Triage for Primary Care and Cardiology
36:00 Reducing Unnecessary Specialist Visits
37:39 Using AI to Route Patients to the Right Hospital
39:00 Fundraising and Strategic Investors
41:00 Clinical Trials and Real-World Evidence
43:14 Early Trial Results and Heart Failure Detection
44:09 The Future of AI-Powered Cardiac Care
45:25 Why Mission Matters More Than Exit Price
47:40 Outro

[Omar M. Khateeb @OmarMKhateeb]

This Month in MedTech: Boston Scientific’s $1.5B Bet and the Rise of Focused Strategics.
Nicholas Talamantes, Sr. Director at (@lsintelligence) Life Science Intelligence, joined me for a deep dive into Q1 earnings, MedTech M&A, strategic focus, and the market signals shaping the next phase of healthcare innovation.
We covered (@bostonsci) Boston Scientific’s $1.5B structural heart bet, the rise of focused strategics, J&J’s Atraverse acquisition, Medtronic’s renewed deal activity, Roche’s expansion into AI-powered pathology, ResMed’s move beyond sleep apnea, and the growing use of option-based deal structures across MedTech.
One of the clearest themes from the episode is that focus is being rewarded.
Companies with concentrated portfolios are delivering stronger growth, while larger platforms continue divesting, acquiring, and repositioning around their highest-value opportunities.
The conversation also explores why commercial proof is becoming the most important trigger for acquisitions, how strategics are approaching risk differently, and what recent earnings reveal about the future direction of MedTech.
For founders, investors, operators, and healthcare leaders, this episode offers a sharp look at where capital, competition, innovation, and market momentum are moving next.

Episode Breakdown
00:00 Why Focused MedTech Companies Are Winning
00:02 Intro + This Month in MedTech
02:03 Q1 Earnings Overview and Market Trends
03:54 AI Hype vs Healthcare Revenue Reality
05:40 What Q1 Earnings Tell Us About MedTech
07:36 Why Focus Beats Diversification
08:55 Edwards Lifesciences' Strong Quarter
10:14 Intuitive Surgical's Growth Engine
11:01 Insulet’s 34% Growth Story
12:52 Why Insulet’s Stock Fell Anyway
16:52 Lessons From Public Market Reactions
18:25 @bostonsci Boston Scientific’s Mixed Quarter
21:22 Stryker’s Cyberattack and Growth Outlook
23:39 @Medtronic's Return to Aggressive M&A
24:53 J&J’s Cardiovascular Growth Strategy
25:39 Abbott’s Cardiovascular Momentum
26:12 Why Cardiovascular Is Dominating MedTech
29:01 Key Takeaways From Q1 Earnings
30:43 Boston Scientific’s $1.5B Structural Heart Bet
31:48 Boston’s Third Attempt at TAVR
34:18 What Makes the Mirus Valve Different?
36:24 Minority Stakes vs Full Acquisitions
37:47 J&J Acquires Atraverse Medical
39:20 The Team Behind Farapulse Strikes Again
41:08 Why Repeat Founders Matter in MedTech
43:20 @AtraverseInc Atraverse Clinical Results Explained
44:57 Where EP Innovation Is Heading Next
47:53 Is MedTech Entering an M&A Boom?
48:53 ResMed Acquires Noctrix Health
49:40 Artivion Buys Endospan
50:34 Roche Acquires PathAI
51:43 Medtronic Acquires SPR Therapeutics
53:17 M&A Trends and Strategic Optionality
55:38 Why More Acquisitions May Be Coming
57:58 The Rise of Option-Based Deal Structures
01:00:35 Speed Round: Notable Funding Deals
01:01:00 Butterfly Medical $21M Series C
01:02:27 SonoMind $23.5M Series A
01:03:45 Aidoc Raises $150M
01:05:30 Illuminant Surgical $8.4M Seed
01:08:06 Perimeter Medical $10.5M Financing
01:10:15 AI, Cancer Care, and Clinical Impact
01:13:05 Biggest Lessons From May 2026
01:17:10 Final Thoughts on Focus, Growth, and M&A
01:22:00 Outro

[State of Medtech Podcast @StateofMedTech]

Why Milestones Alone Don't Build Market Conviction!
Watch the full episode here: 
https://t.co/jJBlk9mESr

[Omar M. Khateeb @OmarMKhateeb]

How the Elephant Slide Helps Healthtech and MedTech Leaders Create Better Board Meetings, Stronger Investor Alignment, and Clearer Strategic Direction.
Most MedTech board meetings overload people with updates but fail to explain what the updates actually mean.
I recently broke down the Elephant Slide framework and why I believe it is one of the most important communication tools a MedTech CEO can learn.
The conversation explores why clinical milestones, financing, commercialization, regulatory timelines, and cash runway cannot be discussed separately in MedTech. Everything is connected. A trial delay changes financing conversations. Commercial traction shapes investor confidence. Market belief impacts adoption long before scale happens.
I also discuss why investor anxiety often comes from missing context instead of bad news itself, and why the strongest CEOs control narrative before the boardroom starts building its own version of the story.
One of the biggest leadership lessons from this episode is simple:Great CEOs do not just present information.
They bring investors, operators, and board members onto the same page around what matters most.
For founders, investors, operators, and MedTech leaders, this is a sharp conversation on boardroom strategy, fundraising psychology, commercialization, and narrative control inside complex healthcare companies.

Episode Breakdown

00:00 Why Board Meetings Go Wrong
00:36 What is an Elephant Slide?
00:57 Intro + Why This Matters for CEOs
01:13 Why You Should Watch This Episode
01:14 The Origin of the Elephant Slide
02:30 Why Most Board Decks Fail
04:00 The Real Problem in Board Meetings
05:40 Why CEOs Must Control the Narrative
06:30 The Blind Men and the Elephant Story
08:10 Why Board Members Get Confused
09:25 The Fictional “Neo” MedTech Example
10:15 Why Data Alone Creates Anxiety
11:17 What Board Members Are Really Thinking
14:32 The “Bottom Line First” Framework
16:00 Why Context Matters More Than Updates
17:30 How Enrollment Delays Affect Financing
18:45 Market Engineering and Board Communication
20:00 Why FDA Clearance Isn’t Enough
21:00 The Most Important Slide in Every Board Deck
22:10 Strategy vs Operations vs Housekeeping
23:00 Why Great CEOs Control the Narrative
23:58 Final Advice for Your Next Board Meeting
24:40 Outro + Subscribe
25:18 End

[State of Medtech Podcast @StateofMedTech]

How Elon Musk Removes Bottlenecks Inside Companies!
Watch the full episode here: 
https://t.co/MS8CwmFaXf

[Omar M. Khateeb @OmarMKhateeb]

Why Barbarians Always Beat Bureaucrats: Hardball Strategy and the Psychology of Winning.

Most organizations do not fail externally first. They decline internally long before the market notices.
I’ve been thinking a lot about why some companies dominate markets for decades while others slowly lose momentum the larger they become.
In this solo episode, I break down one of the most important leadership and business patterns I’ve studied through MedTech, history, and modern technology companies: why barbarian energy consistently outperforms bureaucracy.
Drawing from Barbarians to Bureaucrats, Hardball, Rome, Alexander the Great, Intuitive, @Tesla , @Apple , @amazon , and @McDonalds , I explore how urgency, mission clarity, speed, and disciplined aggression repeatedly shape category-defining organizations.
I also get into why founder mode is really a modern version of barbarian leadership, how bureaucracy slowly creates distance from customers and reality, and why speed itself becomes a strategic advantage in competitive markets.
One of the deeper ideas in the episode is that the companies shaping industries are usually not the ones optimizing for comfort.They are the ones preserving hunger, intensity, and mission obsession while everyone else becomes slower, safer, and more procedural.
For founders, operators, executives, and commercial leaders, this conversation is a framework for understanding organizational decay, competitive psychology, and how winning companies preserve their edge as they scale.

Episode Breakdown:
00:00 Why Great Companies Become Weak
01:12 Intro + Barbarian Leadership Explained
03:20 Crossing the Chasm and Corporate Lifecycles
05:45 Founder Mode vs Bureaucracy
08:00 What is a Barbarian in Business?
10:00 Why Startups Beat Large Corporations
12:10 Prophet vs Barbarian Leadership Styles
14:30 Intuitive Surgical and MedTech Conquest
16:50 Why the Market Rewards Aggression
18:45 Steve Jobs and the Reality Distortion Field
21:00 Why Bureaucracy Kills Innovation
23:20 IBM, Comfort, and Corporate Decline
25:00 Barbarian Traits: Speed, Urgency, Conviction
27:10 Why Simplicity Beats Complexity
29:00 Rome vs Attila the Hun
31:45 Why Civilizations Collapse Internally First
34:00 Alexander the Great and Organizational Power
36:40 @elonmusk and Barbarian Leadership
39:00 Why Speed is a Competitive Weapon
41:15 Hardball Strategy Explained
43:00 Principle 1: Overwhelming Competitive Force
45:00 Principle 2: Exploit Competitor Weakness
47:00 Principle 3: Take Innovation and Scale It
49:00 Principle 4: Force Competitors to Retreat
50:50 Principle 5: Break Industry Assumptions
52:30 Why Founders Struggle to Scale Companies
54:20 Barbarian Energy vs Organizational Systems
55:40 Why Competitive Advantage Never Lasts
56:50 How Companies Lose Their Hunger
57:35 Final Thoughts on Leadership and Competition
58:40 Outro

[State of Medtech Podcast @StateofMedTech]

What Ray Kroc Understood About Scaling Faster Than Competitors!
Watch the full episode here: 
https://t.co/MS8CwmFaXf

[Omar M. Khateeb @OmarMKhateeb]

Why Barbarians Always Beat Bureaucrats: Hardball Strategy and the Psychology of Winning.

Most organizations do not fail externally first. They decline internally long before the market notices.
I’ve been thinking a lot about why some companies dominate markets for decades while others slowly lose momentum the larger they become.
In this solo episode, I break down one of the most important leadership and business patterns I’ve studied through MedTech, history, and modern technology companies: why barbarian energy consistently outperforms bureaucracy.
Drawing from Barbarians to Bureaucrats, Hardball, Rome, Alexander the Great, Intuitive, @Tesla , @Apple , @amazon , and @McDonalds , I explore how urgency, mission clarity, speed, and disciplined aggression repeatedly shape category-defining organizations.
I also get into why founder mode is really a modern version of barbarian leadership, how bureaucracy slowly creates distance from customers and reality, and why speed itself becomes a strategic advantage in competitive markets.
One of the deeper ideas in the episode is that the companies shaping industries are usually not the ones optimizing for comfort.They are the ones preserving hunger, intensity, and mission obsession while everyone else becomes slower, safer, and more procedural.
For founders, operators, executives, and commercial leaders, this conversation is a framework for understanding organizational decay, competitive psychology, and how winning companies preserve their edge as they scale.

Episode Breakdown:
00:00 Why Great Companies Become Weak
01:12 Intro + Barbarian Leadership Explained
03:20 Crossing the Chasm and Corporate Lifecycles
05:45 Founder Mode vs Bureaucracy
08:00 What is a Barbarian in Business?
10:00 Why Startups Beat Large Corporations
12:10 Prophet vs Barbarian Leadership Styles
14:30 Intuitive Surgical and MedTech Conquest
16:50 Why the Market Rewards Aggression
18:45 Steve Jobs and the Reality Distortion Field
21:00 Why Bureaucracy Kills Innovation
23:20 IBM, Comfort, and Corporate Decline
25:00 Barbarian Traits: Speed, Urgency, Conviction
27:10 Why Simplicity Beats Complexity
29:00 Rome vs Attila the Hun
31:45 Why Civilizations Collapse Internally First
34:00 Alexander the Great and Organizational Power
36:40 @elonmusk and Barbarian Leadership
39:00 Why Speed is a Competitive Weapon
41:15 Hardball Strategy Explained
43:00 Principle 1: Overwhelming Competitive Force
45:00 Principle 2: Exploit Competitor Weakness
47:00 Principle 3: Take Innovation and Scale It
49:00 Principle 4: Force Competitors to Retreat
50:50 Principle 5: Break Industry Assumptions
52:30 Why Founders Struggle to Scale Companies
54:20 Barbarian Energy vs Organizational Systems
55:40 Why Competitive Advantage Never Lasts
56:50 How Companies Lose Their Hunger
57:35 Final Thoughts on Leadership and Competition
58:40 Outro

[State of Medtech Podcast @StateofMedTech]

How Bureaucracy Weakens Powerful Organizations Over Time!
Watch the full episode here: 
https://t.co/MS8CwmFaXf

[Omar M. Khateeb @OmarMKhateeb]

Why Barbarians Always Beat Bureaucrats: Hardball Strategy and the Psychology of Winning.

Most organizations do not fail externally first. They decline internally long before the market notices.
I’ve been thinking a lot about why some companies dominate markets for decades while others slowly lose momentum the larger they become.
In this solo episode, I break down one of the most important leadership and business patterns I’ve studied through MedTech, history, and modern technology companies: why barbarian energy consistently outperforms bureaucracy.
Drawing from Barbarians to Bureaucrats, Hardball, Rome, Alexander the Great, Intuitive, @Tesla , @Apple , @amazon , and @McDonalds , I explore how urgency, mission clarity, speed, and disciplined aggression repeatedly shape category-defining organizations.
I also get into why founder mode is really a modern version of barbarian leadership, how bureaucracy slowly creates distance from customers and reality, and why speed itself becomes a strategic advantage in competitive markets.
One of the deeper ideas in the episode is that the companies shaping industries are usually not the ones optimizing for comfort.They are the ones preserving hunger, intensity, and mission obsession while everyone else becomes slower, safer, and more procedural.
For founders, operators, executives, and commercial leaders, this conversation is a framework for understanding organizational decay, competitive psychology, and how winning companies preserve their edge as they scale.

Episode Breakdown:
00:00 Why Great Companies Become Weak
01:12 Intro + Barbarian Leadership Explained
03:20 Crossing the Chasm and Corporate Lifecycles
05:45 Founder Mode vs Bureaucracy
08:00 What is a Barbarian in Business?
10:00 Why Startups Beat Large Corporations
12:10 Prophet vs Barbarian Leadership Styles
14:30 Intuitive Surgical and MedTech Conquest
16:50 Why the Market Rewards Aggression
18:45 Steve Jobs and the Reality Distortion Field
21:00 Why Bureaucracy Kills Innovation
23:20 IBM, Comfort, and Corporate Decline
25:00 Barbarian Traits: Speed, Urgency, Conviction
27:10 Why Simplicity Beats Complexity
29:00 Rome vs Attila the Hun
31:45 Why Civilizations Collapse Internally First
34:00 Alexander the Great and Organizational Power
36:40 @elonmusk and Barbarian Leadership
39:00 Why Speed is a Competitive Weapon
41:15 Hardball Strategy Explained
43:00 Principle 1: Overwhelming Competitive Force
45:00 Principle 2: Exploit Competitor Weakness
47:00 Principle 3: Take Innovation and Scale It
49:00 Principle 4: Force Competitors to Retreat
50:50 Principle 5: Break Industry Assumptions
52:30 Why Founders Struggle to Scale Companies
54:20 Barbarian Energy vs Organizational Systems
55:40 Why Competitive Advantage Never Lasts
56:50 How Companies Lose Their Hunger
57:35 Final Thoughts on Leadership and Competition
58:40 Outro

[State of Medtech Podcast @StateofMedTech]

How AI Could Help Cardiologists Analyze Heart Data in Seconds!
Watch the full episode here: 
https://t.co/S2nDIKtO1u

[Omar M. Khateeb @OmarMKhateeb]

Cardiology has a massive data problem hiding inside a detection problem.Most patients enter the system only after symptoms escalate into an emergency event, even though cardiac deterioration often develops silently over years.
I had the chance to speak with Chris Darland, President & CEO of @PeerbridgeCor , about a category that could redefine how healthcare approaches prevention, monitoring, and cardiac triage:Cardiac intelligence platforms.
In this episode we explore how wearable ECG systems are evolving beyond traditional arrhythmia detection into high fidelity intelligence platforms capable of identifying myocardial stress, structural abnormalities, and broader cardiovascular risk much earlier.
We also discuss why proprietary clinical data is becoming one of the strongest defensibility layers in AI driven MedTech, how intelligent routing could help health systems direct patients to the right level of care faster, and why scalable preventive infrastructure may become one of the biggest opportunities in cardiovascular medicine.
For anyone following AI, digital health, diagnostics, or the future of preventive care, this conversation offers a very interesting look at where the market is heading next.

Episode Breakdown

00:00 Why Cardiac Care is Still Reactive
00:53 Intro + Chris Darland and Peerbridge Health
02:00 Growing Up Around Heart Disease
04:30 From GE to MedTech Startup CEO
05:20 The Real Problem in Cardiology Today
06:49 Scaling Cardiac Care Beyond Hospitals
08:00 Heart Failure and Readmission Crisis
09:00 Arrhythmia Monitoring Explained
10:00 Beyond Arrhythmias: Structural Heart Detection
12:00 AI + ECG for Earlier Detection
13:58 Why Most MedTech Startups Fail After FDA
14:05 Cardiac Intelligence Platform Explained
16:00 Using ECG Data to Detect Heart Disease Early
18:00 Why Signal Fidelity Matters
19:30 AI Layer for Personalized Cardiac Insights
21:30 Building a Defensible AI MedTech Company
23:00 Why Hardware + Unique Data Matter
24:08 Regulatory Strategy and FDA Pathway
26:11 Why MedTech Has Strong AI Defensibility
27:30 NASA Signal Processing and SpaceTech Crossover
29:15 Strategic Partnerships and Acquisition Potential
31:00 Detecting Patients Before Critical Events
33:35 AI Triage for Primary Care and Cardiology
36:00 Reducing Unnecessary Specialist Visits
37:39 Using AI to Route Patients to the Right Hospital
39:00 Fundraising and Strategic Investors
41:00 Clinical Trials and Real-World Evidence
43:14 Early Trial Results and Heart Failure Detection
44:09 The Future of AI-Powered Cardiac Care
45:25 Why Mission Matters More Than Exit Price
47:40 Outro

[State of Medtech Podcast @StateofMedTech]

How Great MedTech Companies Become Strategic Acquisition Targets!
Watch the full episode here: 
https://t.co/S2nDIKtO1u

[Omar M. Khateeb @OmarMKhateeb]

Cardiology has a massive data problem hiding inside a detection problem.Most patients enter the system only after symptoms escalate into an emergency event, even though cardiac deterioration often develops silently over years.
I had the chance to speak with Chris Darland, President & CEO of @PeerbridgeCor , about a category that could redefine how healthcare approaches prevention, monitoring, and cardiac triage:Cardiac intelligence platforms.
In this episode we explore how wearable ECG systems are evolving beyond traditional arrhythmia detection into high fidelity intelligence platforms capable of identifying myocardial stress, structural abnormalities, and broader cardiovascular risk much earlier.
We also discuss why proprietary clinical data is becoming one of the strongest defensibility layers in AI driven MedTech, how intelligent routing could help health systems direct patients to the right level of care faster, and why scalable preventive infrastructure may become one of the biggest opportunities in cardiovascular medicine.
For anyone following AI, digital health, diagnostics, or the future of preventive care, this conversation offers a very interesting look at where the market is heading next.

Episode Breakdown

00:00 Why Cardiac Care is Still Reactive
00:53 Intro + Chris Darland and Peerbridge Health
02:00 Growing Up Around Heart Disease
04:30 From GE to MedTech Startup CEO
05:20 The Real Problem in Cardiology Today
06:49 Scaling Cardiac Care Beyond Hospitals
08:00 Heart Failure and Readmission Crisis
09:00 Arrhythmia Monitoring Explained
10:00 Beyond Arrhythmias: Structural Heart Detection
12:00 AI + ECG for Earlier Detection
13:58 Why Most MedTech Startups Fail After FDA
14:05 Cardiac Intelligence Platform Explained
16:00 Using ECG Data to Detect Heart Disease Early
18:00 Why Signal Fidelity Matters
19:30 AI Layer for Personalized Cardiac Insights
21:30 Building a Defensible AI MedTech Company
23:00 Why Hardware + Unique Data Matter
24:08 Regulatory Strategy and FDA Pathway
26:11 Why MedTech Has Strong AI Defensibility
27:30 NASA Signal Processing and SpaceTech Crossover
29:15 Strategic Partnerships and Acquisition Potential
31:00 Detecting Patients Before Critical Events
33:35 AI Triage for Primary Care and Cardiology
36:00 Reducing Unnecessary Specialist Visits
37:39 Using AI to Route Patients to the Right Hospital
39:00 Fundraising and Strategic Investors
41:00 Clinical Trials and Real-World Evidence
43:14 Early Trial Results and Heart Failure Detection
44:09 The Future of AI-Powered Cardiac Care
45:25 Why Mission Matters More Than Exit Price
47:40 Outro

[State of Medtech Podcast @StateofMedTech]

Why Clinical Superiority Alone Doesn’t Guarantee MedTech Success!
Watch the full episode here: 
https://t.co/naWEoZ97AQ

[Omar M. Khateeb @OmarMKhateeb]

Clinical Superiority Is Essential in MedTech, but Systems Thinking Determines Who Actually Changes Standard of Care.
I sat down with Deborah Kilpatrick, Operator, Director, and Investor in HealthTech & MedTech, alongside Virginia Giddings, Vice President Exploration at Edwards Lifesciences, for a deep conversation on what actually moves healthcare innovation from promising technology to real adoption.
The conversation explores why MedTech startups face long timelines, reimbursement complexity, regulatory pressure, and adoption barriers even when the technology itself is strong. We also discuss how venture capital, strategic MedTech companies, AI-enabled robotics, and minimally invasive therapies are reshaping the future of healthcare.
One of the biggest insights from the episode is simple:
Changing standard of care is not just a product outcome. It is a systems outcome involving workflows, reimbursement, patient access, strategic partnerships, and long-term market development.

For founders, investors, operators, and healthcare leaders, this is a sharp look into the real infrastructure behind transformational MedTech innovation.

Episode Breakdown

00:00 Why Most MedTech Startups Fail
00:14 The Long Path of MedTech Innovation
01:01 Intro + Virginia Giddings and Deb Kilpatrick
02:14 VP of Exploration at Edwards Explained
03:26 Sonder Capital’s Investment Thesis
05:10 Why Transformational Healthcare Matters
06:12 Why Industry Leadership Matters
07:44 Healthcare is Personal for Everyone
09:09 Venture Capital vs Strategic Investors
10:32 Why MedTech Needs a Symbiotic Ecosystem
12:21 Why MedTech is Worth the Risk
13:34 Organic vs Inorganic Innovation
15:40 Why FDA Clearance Isn’t Enough
18:55 Robotics, AI, and the Future of Investing
20:16 How Strategics Work with Venture Capital
21:55 Relationships Drive MedTech Success
23:57 Why Trust Matters in MedTech
24:43 Why MedTech Has Better Exit Visibility
26:44 Why MedTech Still Struggles to Attract Capital
28:33 Product Superiority vs Clinical Superiority
30:34 Why MedTech is Harder Than SaaS
31:05 AI is Reshaping Healthcare
33:14 Why Great Devices Still Fail Adoption
35:04 AI Hype vs Real AI Value
37:56 AI Native Companies vs AI Features
38:53 AI, Robotics, and Human Performance
40:30 AI Safety Loops in Therapeutics
41:12 AI Imaging and Automated Diagnosis
43:22 Consumer Health Data Platforms Explained
45:00 Why MedTech Needs Bigger Bets
46:49 BCI, Consumer Health, and Future Platforms
48:17 Why Healthcare Innovation Needs Systems
50:05 Consumers Are Taking Control of Healthcare
52:55 Cash Pay Healthcare and Insurance Friction
54:04 The Medicare Demographic Shift
55:44 Healthier Generations and Future Healthcare
57:45 Future of Preventive and Longevity Care
58:41 Healthcare Savings and Consumer Empowerment
59:20 One Policy Change That Could Transform Healthcare
01:00:50 Maternal Health and Early Intervention
01:03:02 Rethinking Medicare for the Future
01:06:10 Final Thoughts on Innovation and Healthcare
01:18:00 Outro

[State of Medtech Podcast @StateofMedTech]

The Problem With Waiting Until a Cardiac Emergency Happens!
Watch the full episode here: 
https://t.co/S2nDIKtO1u

[Omar M. Khateeb @OmarMKhateeb]

Cardiology has a massive data problem hiding inside a detection problem.Most patients enter the system only after symptoms escalate into an emergency event, even though cardiac deterioration often develops silently over years.
I had the chance to speak with Chris Darland, President & CEO of @PeerbridgeCor , about a category that could redefine how healthcare approaches prevention, monitoring, and cardiac triage:Cardiac intelligence platforms.
In this episode we explore how wearable ECG systems are evolving beyond traditional arrhythmia detection into high fidelity intelligence platforms capable of identifying myocardial stress, structural abnormalities, and broader cardiovascular risk much earlier.
We also discuss why proprietary clinical data is becoming one of the strongest defensibility layers in AI driven MedTech, how intelligent routing could help health systems direct patients to the right level of care faster, and why scalable preventive infrastructure may become one of the biggest opportunities in cardiovascular medicine.
For anyone following AI, digital health, diagnostics, or the future of preventive care, this conversation offers a very interesting look at where the market is heading next.

Episode Breakdown

00:00 Why Cardiac Care is Still Reactive
00:53 Intro + Chris Darland and Peerbridge Health
02:00 Growing Up Around Heart Disease
04:30 From GE to MedTech Startup CEO
05:20 The Real Problem in Cardiology Today
06:49 Scaling Cardiac Care Beyond Hospitals
08:00 Heart Failure and Readmission Crisis
09:00 Arrhythmia Monitoring Explained
10:00 Beyond Arrhythmias: Structural Heart Detection
12:00 AI + ECG for Earlier Detection
13:58 Why Most MedTech Startups Fail After FDA
14:05 Cardiac Intelligence Platform Explained
16:00 Using ECG Data to Detect Heart Disease Early
18:00 Why Signal Fidelity Matters
19:30 AI Layer for Personalized Cardiac Insights
21:30 Building a Defensible AI MedTech Company
23:00 Why Hardware + Unique Data Matter
24:08 Regulatory Strategy and FDA Pathway
26:11 Why MedTech Has Strong AI Defensibility
27:30 NASA Signal Processing and SpaceTech Crossover
29:15 Strategic Partnerships and Acquisition Potential
31:00 Detecting Patients Before Critical Events
33:35 AI Triage for Primary Care and Cardiology
36:00 Reducing Unnecessary Specialist Visits
37:39 Using AI to Route Patients to the Right Hospital
39:00 Fundraising and Strategic Investors
41:00 Clinical Trials and Real-World Evidence
43:14 Early Trial Results and Heart Failure Detection
44:09 The Future of AI-Powered Cardiac Care
45:25 Why Mission Matters More Than Exit Price
47:40 Outro

[State of Medtech Podcast @StateofMedTech]

Why Life Saving Therapies Still Don’t Reach Enough Patients!
Watch the full episode here: 
https://t.co/naWEoZ97AQ

[Omar M. Khateeb @OmarMKhateeb]

Clinical Superiority Is Essential in MedTech, but Systems Thinking Determines Who Actually Changes Standard of Care.
I sat down with Deborah Kilpatrick, Operator, Director, and Investor in HealthTech & MedTech, alongside Virginia Giddings, Vice President Exploration at Edwards Lifesciences, for a deep conversation on what actually moves healthcare innovation from promising technology to real adoption.
The conversation explores why MedTech startups face long timelines, reimbursement complexity, regulatory pressure, and adoption barriers even when the technology itself is strong. We also discuss how venture capital, strategic MedTech companies, AI-enabled robotics, and minimally invasive therapies are reshaping the future of healthcare.
One of the biggest insights from the episode is simple:
Changing standard of care is not just a product outcome. It is a systems outcome involving workflows, reimbursement, patient access, strategic partnerships, and long-term market development.

For founders, investors, operators, and healthcare leaders, this is a sharp look into the real infrastructure behind transformational MedTech innovation.

Episode Breakdown

00:00 Why Most MedTech Startups Fail
00:14 The Long Path of MedTech Innovation
01:01 Intro + Virginia Giddings and Deb Kilpatrick
02:14 VP of Exploration at Edwards Explained
03:26 Sonder Capital’s Investment Thesis
05:10 Why Transformational Healthcare Matters
06:12 Why Industry Leadership Matters
07:44 Healthcare is Personal for Everyone
09:09 Venture Capital vs Strategic Investors
10:32 Why MedTech Needs a Symbiotic Ecosystem
12:21 Why MedTech is Worth the Risk
13:34 Organic vs Inorganic Innovation
15:40 Why FDA Clearance Isn’t Enough
18:55 Robotics, AI, and the Future of Investing
20:16 How Strategics Work with Venture Capital
21:55 Relationships Drive MedTech Success
23:57 Why Trust Matters in MedTech
24:43 Why MedTech Has Better Exit Visibility
26:44 Why MedTech Still Struggles to Attract Capital
28:33 Product Superiority vs Clinical Superiority
30:34 Why MedTech is Harder Than SaaS
31:05 AI is Reshaping Healthcare
33:14 Why Great Devices Still Fail Adoption
35:04 AI Hype vs Real AI Value
37:56 AI Native Companies vs AI Features
38:53 AI, Robotics, and Human Performance
40:30 AI Safety Loops in Therapeutics
41:12 AI Imaging and Automated Diagnosis
43:22 Consumer Health Data Platforms Explained
45:00 Why MedTech Needs Bigger Bets
46:49 BCI, Consumer Health, and Future Platforms
48:17 Why Healthcare Innovation Needs Systems
50:05 Consumers Are Taking Control of Healthcare
52:55 Cash Pay Healthcare and Insurance Friction
54:04 The Medicare Demographic Shift
55:44 Healthier Generations and Future Healthcare
57:45 Future of Preventive and Longevity Care
58:41 Healthcare Savings and Consumer Empowerment
59:20 One Policy Change That Could Transform Healthcare
01:00:50 Maternal Health and Early Intervention
01:03:02 Rethinking Medicare for the Future
01:06:10 Final Thoughts on Innovation and Healthcare
01:18:00 Outro

[State of Medtech Podcast @StateofMedTech]

How Personal Experience Creates Powerful Healthcare Companies!
Watch the full episode here: 
https://t.co/naWEoZ97AQ

[Omar M. Khateeb @OmarMKhateeb]

Clinical Superiority Is Essential in MedTech, but Systems Thinking Determines Who Actually Changes Standard of Care.
I sat down with Deborah Kilpatrick, Operator, Director, and Investor in HealthTech & MedTech, alongside Virginia Giddings, Vice President Exploration at Edwards Lifesciences, for a deep conversation on what actually moves healthcare innovation from promising technology to real adoption.
The conversation explores why MedTech startups face long timelines, reimbursement complexity, regulatory pressure, and adoption barriers even when the technology itself is strong. We also discuss how venture capital, strategic MedTech companies, AI-enabled robotics, and minimally invasive therapies are reshaping the future of healthcare.
One of the biggest insights from the episode is simple:
Changing standard of care is not just a product outcome. It is a systems outcome involving workflows, reimbursement, patient access, strategic partnerships, and long-term market development.

For founders, investors, operators, and healthcare leaders, this is a sharp look into the real infrastructure behind transformational MedTech innovation.

Episode Breakdown

00:00 Why Most MedTech Startups Fail
00:14 The Long Path of MedTech Innovation
01:01 Intro + Virginia Giddings and Deb Kilpatrick
02:14 VP of Exploration at Edwards Explained
03:26 Sonder Capital’s Investment Thesis
05:10 Why Transformational Healthcare Matters
06:12 Why Industry Leadership Matters
07:44 Healthcare is Personal for Everyone
09:09 Venture Capital vs Strategic Investors
10:32 Why MedTech Needs a Symbiotic Ecosystem
12:21 Why MedTech is Worth the Risk
13:34 Organic vs Inorganic Innovation
15:40 Why FDA Clearance Isn’t Enough
18:55 Robotics, AI, and the Future of Investing
20:16 How Strategics Work with Venture Capital
21:55 Relationships Drive MedTech Success
23:57 Why Trust Matters in MedTech
24:43 Why MedTech Has Better Exit Visibility
26:44 Why MedTech Still Struggles to Attract Capital
28:33 Product Superiority vs Clinical Superiority
30:34 Why MedTech is Harder Than SaaS
31:05 AI is Reshaping Healthcare
33:14 Why Great Devices Still Fail Adoption
35:04 AI Hype vs Real AI Value
37:56 AI Native Companies vs AI Features
38:53 AI, Robotics, and Human Performance
40:30 AI Safety Loops in Therapeutics
41:12 AI Imaging and Automated Diagnosis
43:22 Consumer Health Data Platforms Explained
45:00 Why MedTech Needs Bigger Bets
46:49 BCI, Consumer Health, and Future Platforms
48:17 Why Healthcare Innovation Needs Systems
50:05 Consumers Are Taking Control of Healthcare
52:55 Cash Pay Healthcare and Insurance Friction
54:04 The Medicare Demographic Shift
55:44 Healthier Generations and Future Healthcare
57:45 Future of Preventive and Longevity Care
58:41 Healthcare Savings and Consumer Empowerment
59:20 One Policy Change That Could Transform Healthcare
01:00:50 Maternal Health and Early Intervention
01:03:02 Rethinking Medicare for the Future
01:06:10 Final Thoughts on Innovation and Healthcare
01:18:00 Outro

[State of Medtech Podcast @StateofMedTech]

How Modern Technology Is Unlocking Hidden Heart Signals!
Watch the full episode here: 
https://t.co/S2nDIKtO1u

[Omar M. Khateeb @OmarMKhateeb]

Cardiology has a massive data problem hiding inside a detection problem.Most patients enter the system only after symptoms escalate into an emergency event, even though cardiac deterioration often develops silently over years.
I had the chance to speak with Chris Darland, President & CEO of @PeerbridgeCor , about a category that could redefine how healthcare approaches prevention, monitoring, and cardiac triage:Cardiac intelligence platforms.
In this episode we explore how wearable ECG systems are evolving beyond traditional arrhythmia detection into high fidelity intelligence platforms capable of identifying myocardial stress, structural abnormalities, and broader cardiovascular risk much earlier.
We also discuss why proprietary clinical data is becoming one of the strongest defensibility layers in AI driven MedTech, how intelligent routing could help health systems direct patients to the right level of care faster, and why scalable preventive infrastructure may become one of the biggest opportunities in cardiovascular medicine.
For anyone following AI, digital health, diagnostics, or the future of preventive care, this conversation offers a very interesting look at where the market is heading next.

Episode Breakdown

00:00 Why Cardiac Care is Still Reactive
00:53 Intro + Chris Darland and Peerbridge Health
02:00 Growing Up Around Heart Disease
04:30 From GE to MedTech Startup CEO
05:20 The Real Problem in Cardiology Today
06:49 Scaling Cardiac Care Beyond Hospitals
08:00 Heart Failure and Readmission Crisis
09:00 Arrhythmia Monitoring Explained
10:00 Beyond Arrhythmias: Structural Heart Detection
12:00 AI + ECG for Earlier Detection
13:58 Why Most MedTech Startups Fail After FDA
14:05 Cardiac Intelligence Platform Explained
16:00 Using ECG Data to Detect Heart Disease Early
18:00 Why Signal Fidelity Matters
19:30 AI Layer for Personalized Cardiac Insights
21:30 Building a Defensible AI MedTech Company
23:00 Why Hardware + Unique Data Matter
24:08 Regulatory Strategy and FDA Pathway
26:11 Why MedTech Has Strong AI Defensibility
27:30 NASA Signal Processing and SpaceTech Crossover
29:15 Strategic Partnerships and Acquisition Potential
31:00 Detecting Patients Before Critical Events
33:35 AI Triage for Primary Care and Cardiology
36:00 Reducing Unnecessary Specialist Visits
37:39 Using AI to Route Patients to the Right Hospital
39:00 Fundraising and Strategic Investors
41:00 Clinical Trials and Real-World Evidence
43:14 Early Trial Results and Heart Failure Detection
44:09 The Future of AI-Powered Cardiac Care
45:25 Why Mission Matters More Than Exit Price
47:40 Outro

[State of Medtech Podcast @StateofMedTech]

The Biggest MedTech Winners Change Systems Not Just Products!
Watch the full episode here: 
https://t.co/naWEoZ97AQ

[Omar M. Khateeb @OmarMKhateeb]

Clinical Superiority Is Essential in MedTech, but Systems Thinking Determines Who Actually Changes Standard of Care.
I sat down with Deborah Kilpatrick, Operator, Director, and Investor in HealthTech & MedTech, alongside Virginia Giddings, Vice President Exploration at Edwards Lifesciences, for a deep conversation on what actually moves healthcare innovation from promising technology to real adoption.
The conversation explores why MedTech startups face long timelines, reimbursement complexity, regulatory pressure, and adoption barriers even when the technology itself is strong. We also discuss how venture capital, strategic MedTech companies, AI-enabled robotics, and minimally invasive therapies are reshaping the future of healthcare.
One of the biggest insights from the episode is simple:
Changing standard of care is not just a product outcome. It is a systems outcome involving workflows, reimbursement, patient access, strategic partnerships, and long-term market development.

For founders, investors, operators, and healthcare leaders, this is a sharp look into the real infrastructure behind transformational MedTech innovation.

Episode Breakdown

00:00 Why Most MedTech Startups Fail
00:14 The Long Path of MedTech Innovation
01:01 Intro + Virginia Giddings and Deb Kilpatrick
02:14 VP of Exploration at Edwards Explained
03:26 Sonder Capital’s Investment Thesis
05:10 Why Transformational Healthcare Matters
06:12 Why Industry Leadership Matters
07:44 Healthcare is Personal for Everyone
09:09 Venture Capital vs Strategic Investors
10:32 Why MedTech Needs a Symbiotic Ecosystem
12:21 Why MedTech is Worth the Risk
13:34 Organic vs Inorganic Innovation
15:40 Why FDA Clearance Isn’t Enough
18:55 Robotics, AI, and the Future of Investing
20:16 How Strategics Work with Venture Capital
21:55 Relationships Drive MedTech Success
23:57 Why Trust Matters in MedTech
24:43 Why MedTech Has Better Exit Visibility
26:44 Why MedTech Still Struggles to Attract Capital
28:33 Product Superiority vs Clinical Superiority
30:34 Why MedTech is Harder Than SaaS
31:05 AI is Reshaping Healthcare
33:14 Why Great Devices Still Fail Adoption
35:04 AI Hype vs Real AI Value
37:56 AI Native Companies vs AI Features
38:53 AI, Robotics, and Human Performance
40:30 AI Safety Loops in Therapeutics
41:12 AI Imaging and Automated Diagnosis
43:22 Consumer Health Data Platforms Explained
45:00 Why MedTech Needs Bigger Bets
46:49 BCI, Consumer Health, and Future Platforms
48:17 Why Healthcare Innovation Needs Systems
50:05 Consumers Are Taking Control of Healthcare
52:55 Cash Pay Healthcare and Insurance Friction
54:04 The Medicare Demographic Shift
55:44 Healthier Generations and Future Healthcare
57:45 Future of Preventive and Longevity Care
58:41 Healthcare Savings and Consumer Empowerment
59:20 One Policy Change That Could Transform Healthcare
01:00:50 Maternal Health and Early Intervention
01:03:02 Rethinking Medicare for the Future
01:06:10 Final Thoughts on Innovation and Healthcare
01:18:00 Outro

[State of Medtech Podcast @StateofMedTech]

The Most Exciting AI Opportunity in MedTech Right Now!
Watch the full episode here: 
https://t.co/naWEoZ97AQ

[Omar M. Khateeb @OmarMKhateeb]

Clinical Superiority Is Essential in MedTech, but Systems Thinking Determines Who Actually Changes Standard of Care.
I sat down with Deborah Kilpatrick, Operator, Director, and Investor in HealthTech & MedTech, alongside Virginia Giddings, Vice President Exploration at Edwards Lifesciences, for a deep conversation on what actually moves healthcare innovation from promising technology to real adoption.
The conversation explores why MedTech startups face long timelines, reimbursement complexity, regulatory pressure, and adoption barriers even when the technology itself is strong. We also discuss how venture capital, strategic MedTech companies, AI-enabled robotics, and minimally invasive therapies are reshaping the future of healthcare.
One of the biggest insights from the episode is simple:
Changing standard of care is not just a product outcome. It is a systems outcome involving workflows, reimbursement, patient access, strategic partnerships, and long-term market development.

For founders, investors, operators, and healthcare leaders, this is a sharp look into the real infrastructure behind transformational MedTech innovation.

Episode Breakdown

00:00 Why Most MedTech Startups Fail
00:14 The Long Path of MedTech Innovation
01:01 Intro + Virginia Giddings and Deb Kilpatrick
02:14 VP of Exploration at Edwards Explained
03:26 Sonder Capital’s Investment Thesis
05:10 Why Transformational Healthcare Matters
06:12 Why Industry Leadership Matters
07:44 Healthcare is Personal for Everyone
09:09 Venture Capital vs Strategic Investors
10:32 Why MedTech Needs a Symbiotic Ecosystem
12:21 Why MedTech is Worth the Risk
13:34 Organic vs Inorganic Innovation
15:40 Why FDA Clearance Isn’t Enough
18:55 Robotics, AI, and the Future of Investing
20:16 How Strategics Work with Venture Capital
21:55 Relationships Drive MedTech Success
23:57 Why Trust Matters in MedTech
24:43 Why MedTech Has Better Exit Visibility
26:44 Why MedTech Still Struggles to Attract Capital
28:33 Product Superiority vs Clinical Superiority
30:34 Why MedTech is Harder Than SaaS
31:05 AI is Reshaping Healthcare
33:14 Why Great Devices Still Fail Adoption
35:04 AI Hype vs Real AI Value
37:56 AI Native Companies vs AI Features
38:53 AI, Robotics, and Human Performance
40:30 AI Safety Loops in Therapeutics
41:12 AI Imaging and Automated Diagnosis
43:22 Consumer Health Data Platforms Explained
45:00 Why MedTech Needs Bigger Bets
46:49 BCI, Consumer Health, and Future Platforms
48:17 Why Healthcare Innovation Needs Systems
50:05 Consumers Are Taking Control of Healthcare
52:55 Cash Pay Healthcare and Insurance Friction
54:04 The Medicare Demographic Shift
55:44 Healthier Generations and Future Healthcare
57:45 Future of Preventive and Longevity Care
58:41 Healthcare Savings and Consumer Empowerment
59:20 One Policy Change That Could Transform Healthcare
01:00:50 Maternal Health and Early Intervention
01:03:02 Rethinking Medicare for the Future
01:06:10 Final Thoughts on Innovation and Healthcare
01:18:00 Outro

[State of Medtech Podcast @StateofMedTech]

The AI Breakthrough Opening New Possibilities in Neurology!
Watch the full episode here: 
https://t.co/naWEoZ97AQ

[Omar M. Khateeb @OmarMKhateeb]

Clinical Superiority Is Essential in MedTech, but Systems Thinking Determines Who Actually Changes Standard of Care.
I sat down with Deborah Kilpatrick, Operator, Director, and Investor in HealthTech & MedTech, alongside Virginia Giddings, Vice President Exploration at Edwards Lifesciences, for a deep conversation on what actually moves healthcare innovation from promising technology to real adoption.
The conversation explores why MedTech startups face long timelines, reimbursement complexity, regulatory pressure, and adoption barriers even when the technology itself is strong. We also discuss how venture capital, strategic MedTech companies, AI-enabled robotics, and minimally invasive therapies are reshaping the future of healthcare.
One of the biggest insights from the episode is simple:
Changing standard of care is not just a product outcome. It is a systems outcome involving workflows, reimbursement, patient access, strategic partnerships, and long-term market development.

For founders, investors, operators, and healthcare leaders, this is a sharp look into the real infrastructure behind transformational MedTech innovation.

Episode Breakdown

00:00 Why Most MedTech Startups Fail
00:14 The Long Path of MedTech Innovation
01:01 Intro + Virginia Giddings and Deb Kilpatrick
02:14 VP of Exploration at Edwards Explained
03:26 Sonder Capital’s Investment Thesis
05:10 Why Transformational Healthcare Matters
06:12 Why Industry Leadership Matters
07:44 Healthcare is Personal for Everyone
09:09 Venture Capital vs Strategic Investors
10:32 Why MedTech Needs a Symbiotic Ecosystem
12:21 Why MedTech is Worth the Risk
13:34 Organic vs Inorganic Innovation
15:40 Why FDA Clearance Isn’t Enough
18:55 Robotics, AI, and the Future of Investing
20:16 How Strategics Work with Venture Capital
21:55 Relationships Drive MedTech Success
23:57 Why Trust Matters in MedTech
24:43 Why MedTech Has Better Exit Visibility
26:44 Why MedTech Still Struggles to Attract Capital
28:33 Product Superiority vs Clinical Superiority
30:34 Why MedTech is Harder Than SaaS
31:05 AI is Reshaping Healthcare
33:14 Why Great Devices Still Fail Adoption
35:04 AI Hype vs Real AI Value
37:56 AI Native Companies vs AI Features
38:53 AI, Robotics, and Human Performance
40:30 AI Safety Loops in Therapeutics
41:12 AI Imaging and Automated Diagnosis
43:22 Consumer Health Data Platforms Explained
45:00 Why MedTech Needs Bigger Bets
46:49 BCI, Consumer Health, and Future Platforms
48:17 Why Healthcare Innovation Needs Systems
50:05 Consumers Are Taking Control of Healthcare
52:55 Cash Pay Healthcare and Insurance Friction
54:04 The Medicare Demographic Shift
55:44 Healthier Generations and Future Healthcare
57:45 Future of Preventive and Longevity Care
58:41 Healthcare Savings and Consumer Empowerment
59:20 One Policy Change That Could Transform Healthcare
01:00:50 Maternal Health and Early Intervention
01:03:02 Rethinking Medicare for the Future
01:06:10 Final Thoughts on Innovation and Healthcare
01:18:00 Outro

[State of Medtech Podcast @StateofMedTech]

The Leadership Trait That Helped Steve Jobs Change Entire Markets!
Watch the full episode here: 
https://t.co/MS8CwmFaXf

[Omar M. Khateeb @OmarMKhateeb]

Why Barbarians Always Beat Bureaucrats: Hardball Strategy and the Psychology of Winning.

Most organizations do not fail externally first. They decline internally long before the market notices.
I’ve been thinking a lot about why some companies dominate markets for decades while others slowly lose momentum the larger they become.
In this solo episode, I break down one of the most important leadership and business patterns I’ve studied through MedTech, history, and modern technology companies: why barbarian energy consistently outperforms bureaucracy.
Drawing from Barbarians to Bureaucrats, Hardball, Rome, Alexander the Great, Intuitive, @Tesla , @Apple , @amazon , and @McDonalds , I explore how urgency, mission clarity, speed, and disciplined aggression repeatedly shape category-defining organizations.
I also get into why founder mode is really a modern version of barbarian leadership, how bureaucracy slowly creates distance from customers and reality, and why speed itself becomes a strategic advantage in competitive markets.
One of the deeper ideas in the episode is that the companies shaping industries are usually not the ones optimizing for comfort.They are the ones preserving hunger, intensity, and mission obsession while everyone else becomes slower, safer, and more procedural.
For founders, operators, executives, and commercial leaders, this conversation is a framework for understanding organizational decay, competitive psychology, and how winning companies preserve their edge as they scale.

Episode Breakdown:
00:00 Why Great Companies Become Weak
01:12 Intro + Barbarian Leadership Explained
03:20 Crossing the Chasm and Corporate Lifecycles
05:45 Founder Mode vs Bureaucracy
08:00 What is a Barbarian in Business?
10:00 Why Startups Beat Large Corporations
12:10 Prophet vs Barbarian Leadership Styles
14:30 Intuitive Surgical and MedTech Conquest
16:50 Why the Market Rewards Aggression
18:45 Steve Jobs and the Reality Distortion Field
21:00 Why Bureaucracy Kills Innovation
23:20 IBM, Comfort, and Corporate Decline
25:00 Barbarian Traits: Speed, Urgency, Conviction
27:10 Why Simplicity Beats Complexity
29:00 Rome vs Attila the Hun
31:45 Why Civilizations Collapse Internally First
34:00 Alexander the Great and Organizational Power
36:40 @elonmusk and Barbarian Leadership
39:00 Why Speed is a Competitive Weapon
41:15 Hardball Strategy Explained
43:00 Principle 1: Overwhelming Competitive Force
45:00 Principle 2: Exploit Competitor Weakness
47:00 Principle 3: Take Innovation and Scale It
49:00 Principle 4: Force Competitors to Retreat
50:50 Principle 5: Break Industry Assumptions
52:30 Why Founders Struggle to Scale Companies
54:20 Barbarian Energy vs Organizational Systems
55:40 Why Competitive Advantage Never Lasts
56:50 How Companies Lose Their Hunger
57:35 Final Thoughts on Leadership and Competition
58:40 Outro

[State of Medtech Podcast @StateofMedTech]

Google Didn’t Just Organize Information It Organized Attention!
Watch the full episode here: 
https://t.co/5Wfa15ogoZ

[Omar M. Khateeb @OmarMKhateeb]

Recently @chamath was on Joe Rogan and covered a topic that is arguably the most important ideas shaping AI, media, and markets right now:
Attention as the operating system.

In this episode I break down how Google organized attention with search, how social media turned it into an engagement machine, and how today’s AI models (via transformers) are now operationalizing it at scale.
We also explore why repetition creates belief, why outrage wins algorithms, and why market positioning is really just attention allocation over time.

If you’re a founder, marketer, or operator trying to understand influence, narrative, and leverage in the AI era this one’s for you.

Episode Breakdown

00:00 Attention is the Foundation of AI and Modern Life
01:15 Intro + Why Attention Matters
03:00 Attention Shapes Reality
05:17 The Brain’s Spotlight Effect
07:20 Depression, Love, and Attention Patterns
08:45 The Magnifying Glass Analogy
10:05 Why Focus Creates Extraordinary Results
11:00 Elon Musk, Bottlenecks, and Concentrated Attention
14:28 Your Life Reflects What You Feed Attention To
15:00 Chamath Palihapitiya’s Attention Theory
16:05 How Google Organized Human Attention
18:00 Social Media Monetized Attention
19:30 Why Algorithms Reward Outrage and Fear
21:00 “Attention Is All You Need” Explained
22:10 How AI Uses Attention Mechanisms
23:00 AI, Transformers, and Machine Attention
23:46 Attention vs Truth
25:20 Why Society Focuses on the Wrong Problems
27:00 The Psychology of Polarization and Virality
28:30 Why Young People Want to Become Influencers
29:46 Attention, Outcomes, and the Process
31:00 Why Great Founders Focus on Process
32:15 Flow States and Deep Work
33:35 Parenting, Presence, and Attention
34:30 Marketing is About Directing Attention
35:30 Perception, Meaning, and Repetition
37:00 Why Repetition Creates Belief
39:00 Attention Engineering in Marketing
40:15 Why Most Marketing Fails
41:00 Audit Your Attention This Week
42:50 Final Thoughts on AI, Attention, and Reality
44:03 Outro

[State of Medtech Podcast @StateofMedTech]

How Technology Learned to Compete for Human Attention!
Watch the full episode here: 
https://t.co/5Wfa15ogoZ

[Omar M. Khateeb @OmarMKhateeb]

Recently @chamath was on Joe Rogan and covered a topic that is arguably the most important ideas shaping AI, media, and markets right now:
Attention as the operating system.

In this episode I break down how Google organized attention with search, how social media turned it into an engagement machine, and how today’s AI models (via transformers) are now operationalizing it at scale.
We also explore why repetition creates belief, why outrage wins algorithms, and why market positioning is really just attention allocation over time.

If you’re a founder, marketer, or operator trying to understand influence, narrative, and leverage in the AI era this one’s for you.

Episode Breakdown

00:00 Attention is the Foundation of AI and Modern Life
01:15 Intro + Why Attention Matters
03:00 Attention Shapes Reality
05:17 The Brain’s Spotlight Effect
07:20 Depression, Love, and Attention Patterns
08:45 The Magnifying Glass Analogy
10:05 Why Focus Creates Extraordinary Results
11:00 Elon Musk, Bottlenecks, and Concentrated Attention
14:28 Your Life Reflects What You Feed Attention To
15:00 Chamath Palihapitiya’s Attention Theory
16:05 How Google Organized Human Attention
18:00 Social Media Monetized Attention
19:30 Why Algorithms Reward Outrage and Fear
21:00 “Attention Is All You Need” Explained
22:10 How AI Uses Attention Mechanisms
23:00 AI, Transformers, and Machine Attention
23:46 Attention vs Truth
25:20 Why Society Focuses on the Wrong Problems
27:00 The Psychology of Polarization and Virality
28:30 Why Young People Want to Become Influencers
29:46 Attention, Outcomes, and the Process
31:00 Why Great Founders Focus on Process
32:15 Flow States and Deep Work
33:35 Parenting, Presence, and Attention
34:30 Marketing is About Directing Attention
35:30 Perception, Meaning, and Repetition
37:00 Why Repetition Creates Belief
39:00 Attention Engineering in Marketing
40:15 Why Most Marketing Fails
41:00 Audit Your Attention This Week
42:50 Final Thoughts on AI, Attention, and Reality
44:03 Outro